SCHEMBL15630971

SCHEMBL15630971

Cc1c(N)cccc1C(=O)NCC(=O)O

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KEAP1 Q14145 1/20 0.49
▸ KDM4E B2RXH2 7/20 0.47
▸ MAPT P10636 1/20 0.47
▸ HIF1A Q16665 1/20 0.47
▸ SLC22A6 Q4U2R8 1/20 0.47
▸ SLC22A8 Q8TCC7 1/20 0.47
▸ ALDH1A1 P00352 6/20 0.47
▸ HPGD P15428 6/20 0.47
▸ HSD17B10 Q99714 3/20 0.47
▸ NSD2 O96028 2/20 0.47
▸ RAB9A P51151 2/20 0.46
▸ NPC1 O15118 1/20 0.46
▸ CASP3 P42574 1/20 0.46
▸ SENP8 Q96LD8 1/20 0.46
▸ SENP7 Q9BQF6 1/20 0.46
▸ SENP6 Q9GZR1 1/20 0.46
▸ GAA P10253 1/20 0.45
▸ EGLN1 Q9GZT9 2/20 0.44
▸ POLB P06746 2/20 0.44
▸ KMT2A Q03164 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12311981 0.83 MMP2 (0.59) KEAP1KDM4EMAPTHIF1ASLC22A6
SCHEMBL28539525 0.83 ALDH1A1 (0.49) KDM4EALDH1A1HPGDHSD17B10NSD2
SCHEMBL196585 0.83 ALDH1A1 (0.55) KEAP1KDM4EMAPTHIF1ASLC22A6
SCHEMBL4062229 0.81 ALDH1A1 (0.54) KEAP1KDM4EMAPTHIF1ASLC22A6
SCHEMBL28160698 0.81 ALDH1A1 (0.54) KEAP1KDM4EMAPTHIF1ASLC22A6
SCHEMBL436270 0.81 KEAP1 (0.49) KEAP1MAPTHPGDRAB9AGAA
SCHEMBL12031886 0.79 RAB9A (0.49) KDM4ERAB9ANPC1POLBKMT2A
SCHEMBL13281184 0.78 HPGD (0.56) KDM4EALDH1A1HPGDHSD17B10GAA
SCHEMBL436284 0.78 KEAP1 (0.57) KEAP1ALDH1A1RAB9AEGLN1
SCHEMBL2299529 0.78 PLK1 (0.50) KDM4EMAPTALDH1A1HPGDHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8906344-B2 F-18 radiolabeled compounds for diagnosing and monitoring kidney function KASINA LAILA INNOVA PHARMACEUTICALS PRIVATE LIMITED (IN) 2014-12-09 — — US disclosed
US-20140086837-A1 F-18 RADIOLABELED COMPOUNDS FOR DIAGNOSING AND MONITORING KIDNEY FUNCTION KASINA LAILA INNOVA PHARMACEUTICALS PRIVATE LIMITED (IN) 2014-03-27 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140086837-A1 F-18 RADIOLABELED COMPOUNDS FOR DIAGNOSING AND MONITORING KIDNEY FUNCTION SLCO1B1, SLCO1B3, SLCO2B1 KEAP1 1403/4885KDM4E 2852/4885MAPT 2622/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback